Latest filing published 06 Jul 2026 for Kane Biotech Inc., €16k.
Insider track record
No signal scores available.
Marianne Greven: trading record in brief
Marianne Greven discloses dealings in Kane Biotech Inc. to SEDI. In total, 2 filings cover trades dated from 25 June 2025 to 28 May 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 July 2026, the filings show an option exercise worth €16k in Kane Biotech Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marianne Greven
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500,000 shares@ CA$0.05100.0% of flowOptionsTSXSEDI:4746382
- OptionsTSXSEDI:4746327
2 of 2 declarations